Importantly, FBXL6-low_MW was identified exclusively in AML cell lines, particularly of the M4 and M5 subtypes (according to the FAB classification) and not any other of the investigated hematological or solid cancer entities (Fig. 2A, B). The gene discussed is FBXL6; the disease is acute myeloid leukemia.